期刊文献+

左室功能正常的不稳定型心绞痛患者血清NT-pro-BNP水平的影响因素探讨 被引量:2

Determinants of N-terminal proBNP Levels in Ustable Angina Patients with Preserved Left Ventricular Function
下载PDF
导出
摘要 目的探讨左室功能正常的不稳定型心绞痛患者血清NT-pro-BNP水平的影响因素。方法选取133例临床诊断不稳定型心绞痛患者,心超证实左室射血分数>50%,入院后收集患者的一般临床资料,并行冠脉造影,任何一支主要血管狭窄>75%定义为冠脉造影阳性。所有患者采用罗氏CARDIAC proBNP+检测仪测定NT-proBNP水平。结果采用多重线性回归分析探讨NT-proBNP水平的影响因素,纳入变量包括患者年龄、性别、高血压、抽烟、糖尿病、心房纤颤、冠脉支架置入(PCI术)史、左室射血分数(LVEF)值、冠脉造影结果等。结果提示,年龄、心房纤颤和冠脉造影阳性和NT-proBNP水平呈显著正相关,其中冠脉造影结果对NT-proBNP水平的影响最大,心房纤颤其次,年龄的影响最小。结论冠状动脉狭窄可导致心功能正常的不稳定型心绞痛患者血NT-proBNP水平显著升高,同时,心房纤颤和年龄也是NT-proBNP水平升高的独立预测因子。 Objective To investigate the factors influencing plasma NT - proBNP levels in ustable angina patients with preserved left ventricular function. Methods A total of 133 patients with primary diagnosis of unstable angina were enrolled into this study. The left ventricular ejection fraction of all patients were 〉 50% confirmed by echocardiogram. The clinical data were collected after admission and angiography was perfoimed by experienced cardiologist. Stenosis 〉 75% in any major vessels was defined as angiography positive. NT- proBNP level was determined by CARDIAC proBNP + machine. Results Multiple linear regression was performed to investigate the fac- tors influencing NT -proBNP levels and the included variables were age, gender, hypertension, smoke, diabetes, atrial fibrillation, histo-ry of PCI, left ventricular ejection fraction, and angiography. The resuhs showed that angiography, age and atrial fibrillation were signifi-cantly correlated with NT - proBNP( the standard coefficient was 0,384, O. 244 and 0. 264, respectively ; P 〈 0.05 ). Conclusion NT -proBNP level was found to increase with the significant stenosis of coronary artery. Age and atrial fibrillation were also independently cor-related with NT - proBNP level.
出处 《医学研究杂志》 2012年第10期98-101,共4页 Journal of Medical Research
基金 杭州市科技局重点项目(20080333Q03)
关键词 不稳定性心绞痛 氨基末端脑钠肽前体 冠脉造影 Ustable angina N - terminal proBNP Angiography
  • 相关文献

参考文献1

二级参考文献16

  • 1Bozkurt B,Mann DL. Use of biomarkers in the management of heart failure. Are we there yet? Circulation ,2003,107 : 1231-1233.
  • 2White HD,French JK. Use of brain natriuretic peptide levels for risk assessment in non-ST-elevation acute coronary syndromes. J Am Coll Cardiol,2003,42 : 1917-1920.
  • 3Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure. European Society of Cardiology. Euro Heart J,2001,22 : 1527-1560.
  • 4Hunt SA,Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation ,2005,112 :e154-e235.
  • 5de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet ,2003,362:316-322.
  • 6Yeo KTJ, Wu AHB, Apple FS, et al. Muhicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta,2003,338 : 107-115.
  • 7Vasan RS. Expanding indications for natriuretic peptides:impottance of better new (research) protocols. Am Heart J ,2004,148:743-746.
  • 8Panteghini M,Pagani F,Yeo KTJ,et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem,2004,50:327-332.
  • 9Jaffe AS, Katus H. Acute coronary syndrome biomarkers: the need for more adequate reporting. Circulation ,2004,110 : 104-106.
  • 10Redfield MM, Rodeheffer R J, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration : impact of age and gender. J Am Coll Cardiol,2002 ,40 :976-982.

共引文献65

同被引文献32

  • 1朱伟,赵子彦,靳刚.急性心肌梗死诊断的生物化学标志物研究进展[J].国外医学(临床生物化学与检验学分册),2005,26(2):86-88. 被引量:45
  • 2石军.新生儿窒息心脏收缩功能损害的超声心动图观察及临床意义[J].宁夏医学杂志,2006,28(1):27-29. 被引量:8
  • 3CALEMA T U,YAP S C,GELEIJNES M L,et al. Early detection of left ventricular dysfunction by Doppler tissue imaging and NT-proBNP-type natriuretic peptide in pa- tients with symptomatic serene aortic stenosis[J]. AM Soc Echocardiogr, 2007,21 : 257- 261.
  • 4BENAMER H,STEG PG, BENESSANO J, et al. Elevat- ed cardiac troponin I predicts a high-risk angina graphic a- natomy of the culprit lesion in unstable angina[J]. Am Heart J, 2004,137 : 815 - 820.
  • 5KOTASKA K, POPELOVA J, TISEROVA M, et al. NT- proBNP and BNP value in cardiac patients with different degree of left ventricular systolic dysfunction[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2006, 150:125-130.
  • 6BARBOSA M M, NUNES M C P, RIBEIRO A L P, et al. N-terminal proBNP levels in patients with changes dis- ease:A marker of systolic and diastolic dysfunction of the reft ventricler. Eur .1 Eehocardiography, 2007,8 : 204 - 212.
  • 7HEESCHEN C, HAMM C W, MITROVIC V, et al. 1N terminal proBNP Natriuretic Peptide level for dynamic risk stratification of patients with acute coronary syn- dromes[J]. Circulation, 2010,110:3206- 3212.
  • 8DAVUTOGLU V, GUNAY N, KOCOGLU H, et al. Ser- um levels of NT-proBNP as an early cardiac marker of carbon monoxide poisoning[J]. Inhal Toxicol, 2006,18: 155-158.
  • 9AOKI H, YAMAMOTO I, MORITA S, et al. Clinical a- nalysis of acute carbon monoxide poisoning with myocar- dial injury[J]. Chudoku Kenkyu, 2012,25 : 305 - 308.
  • 10TEKSAM O, GUMUS P, BAYRAKCI B, et al. Acute cardiac effects of carbon monoxide poisoning in children [J]. Eur J Emerg Med, 2010,17 :192 - 196.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部